Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. SNOA Peers
See (SNOA) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SNOA | $3.71 | +15.94% | 6.4M | -1.41 | -$2.79 | N/A |
| ZTS | $155.33 | -1.86% | 70.7B | 28.46 | $5.58 | +1.17% |
| TAK | $14.67 | -3.07% | 46.7B | 64.46 | $0.23 | +3.97% |
| HLN | $9.96 | -0.90% | 45.4B | 23.49 | $0.43 | +1.66% |
| TEVA | $16.29 | -2.54% | 18.9B | -14.37 | -$1.15 | N/A |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| NBIX | $133.98 | +0.35% | 13.4B | 45.73 | $2.95 | N/A |
| RDY | $14.51 | -1.73% | 12.2B | 18.59 | $0.79 | +0.65% |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| VTRS | $9.13 | -1.08% | 10.9B | -2.91 | -$3.18 | +6.47% |
Stock Comparison
SNOA vs ZTS Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ZTS has a market cap of 70.7B. Regarding current trading prices, SNOA is priced at $3.71, while ZTS trades at $155.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ZTS's P/E ratio is 28.46. In terms of profitability, SNOA's ROE is -0.71%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, SNOA is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs TAK Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, TAK has a market cap of 46.7B. Regarding current trading prices, SNOA is priced at $3.71, while TAK trades at $14.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas TAK's P/E ratio is 64.46. In terms of profitability, SNOA's ROE is -0.71%, compared to TAK's ROE of +0.04%. Regarding short-term risk, SNOA is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs HLN Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, HLN has a market cap of 45.4B. Regarding current trading prices, SNOA is priced at $3.71, while HLN trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas HLN's P/E ratio is 23.49. In terms of profitability, SNOA's ROE is -0.71%, compared to HLN's ROE of +0.09%. Regarding short-term risk, SNOA is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs TEVA Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, TEVA has a market cap of 18.9B. Regarding current trading prices, SNOA is priced at $3.71, while TEVA trades at $16.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas TEVA's P/E ratio is -14.37. In terms of profitability, SNOA's ROE is -0.71%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, SNOA is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ITCI Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, SNOA is priced at $3.71, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ITCI's P/E ratio is -180.64. In terms of profitability, SNOA's ROE is -0.71%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, SNOA is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs NBIX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, NBIX has a market cap of 13.4B. Regarding current trading prices, SNOA is priced at $3.71, while NBIX trades at $133.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas NBIX's P/E ratio is 45.73. In terms of profitability, SNOA's ROE is -0.71%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, SNOA is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs RDY Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, RDY has a market cap of 12.2B. Regarding current trading prices, SNOA is priced at $3.71, while RDY trades at $14.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas RDY's P/E ratio is 18.59. In terms of profitability, SNOA's ROE is -0.71%, compared to RDY's ROE of +0.18%. Regarding short-term risk, SNOA is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs CTLT Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, SNOA is priced at $3.71, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas CTLT's P/E ratio is -27.84. In terms of profitability, SNOA's ROE is -0.71%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, SNOA is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs VTRS Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, VTRS has a market cap of 10.9B. Regarding current trading prices, SNOA is priced at $3.71, while VTRS trades at $9.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas VTRS's P/E ratio is -2.91. In terms of profitability, SNOA's ROE is -0.71%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, SNOA is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs RGC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, RGC has a market cap of 8.2B. Regarding current trading prices, SNOA is priced at $3.71, while RGC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas RGC's P/E ratio is -1656.50. In terms of profitability, SNOA's ROE is -0.71%, compared to RGC's ROE of -0.25%. Regarding short-term risk, SNOA is more volatile compared to RGC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ELAN Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ELAN has a market cap of 7.5B. Regarding current trading prices, SNOA is priced at $3.71, while ELAN trades at $14.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ELAN's P/E ratio is 20.07. In terms of profitability, SNOA's ROE is -0.71%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, SNOA is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs LNTH Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, LNTH has a market cap of 5.8B. Regarding current trading prices, SNOA is priced at $3.71, while LNTH trades at $81.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas LNTH's P/E ratio is 22.97. In terms of profitability, SNOA's ROE is -0.71%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, SNOA is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs AMRX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, AMRX has a market cap of 3.9B. Regarding current trading prices, SNOA is priced at $3.71, while AMRX trades at $8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas AMRX's P/E ratio is -210.00. In terms of profitability, SNOA's ROE is -0.71%, compared to AMRX's ROE of -0.07%. Regarding short-term risk, SNOA is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs PRGO Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, PRGO has a market cap of 3.7B. Regarding current trading prices, SNOA is priced at $3.71, while PRGO trades at $27.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas PRGO's P/E ratio is -22.72. In terms of profitability, SNOA's ROE is -0.71%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, SNOA is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs HCM Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, HCM has a market cap of 2.8B. Regarding current trading prices, SNOA is priced at $3.71, while HCM trades at $16.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas HCM's P/E ratio is 80.25. In terms of profitability, SNOA's ROE is -0.71%, compared to HCM's ROE of +0.05%. Regarding short-term risk, SNOA is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ALVOW Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ALVOW has a market cap of 2.6B. Regarding current trading prices, SNOA is priced at $3.71, while ALVOW trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ALVOW's P/E ratio is N/A. In terms of profitability, SNOA's ROE is -0.71%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, SNOA is less volatile compared to ALVOW. This indicates potentially lower risk in terms of short-term price fluctuations for SNOA.
SNOA vs ALVO Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ALVO has a market cap of 2.6B. Regarding current trading prices, SNOA is priced at $3.71, while ALVO trades at $8.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ALVO's P/E ratio is 23.62. In terms of profitability, SNOA's ROE is -0.71%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, SNOA is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs BHC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, BHC has a market cap of 2.5B. Regarding current trading prices, SNOA is priced at $3.71, while BHC trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas BHC's P/E ratio is -55.25. In terms of profitability, SNOA's ROE is -0.71%, compared to BHC's ROE of +0.05%. Regarding short-term risk, SNOA is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs DCPH Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, SNOA is priced at $3.71, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas DCPH's P/E ratio is -11.58. In terms of profitability, SNOA's ROE is -0.71%, compared to DCPH's ROE of -0.28%. Regarding short-term risk, SNOA is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs INDV Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, INDV has a market cap of 1.9B. Regarding current trading prices, SNOA is priced at $3.71, while INDV trades at $15.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas INDV's P/E ratio is -307.40. In terms of profitability, SNOA's ROE is -0.71%, compared to INDV's ROE of -0.01%. Regarding short-term risk, SNOA is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs EMBCV Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, SNOA is priced at $3.71, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas EMBCV's P/E ratio is N/A. In terms of profitability, SNOA's ROE is -0.71%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, SNOA is more volatile compared to EMBCV. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs SUPN Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, SUPN has a market cap of 1.9B. Regarding current trading prices, SNOA is priced at $3.71, while SUPN trades at $33.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas SUPN's P/E ratio is 29.86. In terms of profitability, SNOA's ROE is -0.71%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, SNOA is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs BGM Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, BGM has a market cap of 1.7B. Regarding current trading prices, SNOA is priced at $3.71, while BGM trades at $9.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas BGM's P/E ratio is -47.52. In terms of profitability, SNOA's ROE is -0.71%, compared to BGM's ROE of -0.03%. Regarding short-term risk, SNOA is more volatile compared to BGM. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs TARO Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, SNOA is priced at $3.71, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas TARO's P/E ratio is 30.05. In terms of profitability, SNOA's ROE is -0.71%, compared to TARO's ROE of +0.02%. Regarding short-term risk, SNOA is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs EVO Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, EVO has a market cap of 1.5B. Regarding current trading prices, SNOA is priced at $3.71, while EVO trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas EVO's P/E ratio is -6.04. In terms of profitability, SNOA's ROE is -0.71%, compared to EVO's ROE of -0.22%. Regarding short-term risk, SNOA is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ANIP Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ANIP has a market cap of 1.4B. Regarding current trading prices, SNOA is priced at $3.71, while ANIP trades at $64.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ANIP's P/E ratio is -56.05. In terms of profitability, SNOA's ROE is -0.71%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, SNOA is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs DVAX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, DVAX has a market cap of 1.3B. Regarding current trading prices, SNOA is priced at $3.71, while DVAX trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas DVAX's P/E ratio is -21.78. In terms of profitability, SNOA's ROE is -0.71%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, SNOA is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs PAHC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, PAHC has a market cap of 1.3B. Regarding current trading prices, SNOA is priced at $3.71, while PAHC trades at $30.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas PAHC's P/E ratio is 39.90. In terms of profitability, SNOA's ROE is -0.71%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, SNOA is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs FLXN Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, FLXN has a market cap of 1.3B. Regarding current trading prices, SNOA is priced at $3.71, while FLXN trades at $25.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas FLXN's P/E ratio is N/A. In terms of profitability, SNOA's ROE is -0.71%, compared to FLXN's ROE of +6.19%. Regarding short-term risk, SNOA is more volatile compared to FLXN. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs HROW Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, HROW has a market cap of 1.2B. Regarding current trading prices, SNOA is priced at $3.71, while HROW trades at $34.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas HROW's P/E ratio is -51.38. In terms of profitability, SNOA's ROE is -0.71%, compared to HROW's ROE of -0.36%. Regarding short-term risk, SNOA is more volatile compared to HROW. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs PCRX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, PCRX has a market cap of 1.1B. Regarding current trading prices, SNOA is priced at $3.71, while PCRX trades at $23.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas PCRX's P/E ratio is -10.59. In terms of profitability, SNOA's ROE is -0.71%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, SNOA is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs COLL Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, COLL has a market cap of 1.1B. Regarding current trading prices, SNOA is priced at $3.71, while COLL trades at $32.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas COLL's P/E ratio is 27.06. In terms of profitability, SNOA's ROE is -0.71%, compared to COLL's ROE of +0.19%. Regarding short-term risk, SNOA is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs AMPH Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, AMPH has a market cap of 1B. Regarding current trading prices, SNOA is priced at $3.71, while AMPH trades at $21.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas AMPH's P/E ratio is 8.05. In terms of profitability, SNOA's ROE is -0.71%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, SNOA is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs AVDL Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, AVDL has a market cap of 947.6M. Regarding current trading prices, SNOA is priced at $3.71, while AVDL trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas AVDL's P/E ratio is -37.62. In terms of profitability, SNOA's ROE is -0.71%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, SNOA is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs PETQ Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, SNOA is priced at $3.71, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas PETQ's P/E ratio is 83.73. In terms of profitability, SNOA's ROE is -0.71%, compared to PETQ's ROE of +0.05%. Regarding short-term risk, SNOA is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs CRON Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, CRON has a market cap of 811.3M. Regarding current trading prices, SNOA is priced at $3.71, while CRON trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas CRON's P/E ratio is 15.04. In terms of profitability, SNOA's ROE is -0.71%, compared to CRON's ROE of +0.05%. Regarding short-term risk, SNOA is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs TLRY Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, TLRY has a market cap of 662.4M. Regarding current trading prices, SNOA is priced at $3.71, while TLRY trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas TLRY's P/E ratio is -0.58. In terms of profitability, SNOA's ROE is -0.71%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, SNOA is more volatile compared to TLRY. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs EMBC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, EMBC has a market cap of 627.6M. Regarding current trading prices, SNOA is priced at $3.71, while EMBC trades at $10.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas EMBC's P/E ratio is 12.07. In terms of profitability, SNOA's ROE is -0.71%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, SNOA is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs EOLS Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, EOLS has a market cap of 626.7M. Regarding current trading prices, SNOA is priced at $3.71, while EOLS trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas EOLS's P/E ratio is -10.92. In terms of profitability, SNOA's ROE is -0.71%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, SNOA is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs BDSI Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, SNOA is priced at $3.71, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas BDSI's P/E ratio is 6.82. In terms of profitability, SNOA's ROE is -0.71%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, SNOA is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ORGO Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ORGO has a market cap of 558M. Regarding current trading prices, SNOA is priced at $3.71, while ORGO trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ORGO's P/E ratio is -27.49. In terms of profitability, SNOA's ROE is -0.71%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, SNOA is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs SIGA Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, SIGA has a market cap of 493.7M. Regarding current trading prices, SNOA is priced at $3.71, while SIGA trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas SIGA's P/E ratio is 10.31. In terms of profitability, SNOA's ROE is -0.71%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, SNOA is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs KMDA Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, KMDA has a market cap of 461.2M. Regarding current trading prices, SNOA is priced at $3.71, while KMDA trades at $7.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas KMDA's P/E ratio is 28.64. In terms of profitability, SNOA's ROE is -0.71%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, SNOA is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs AQST Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, AQST has a market cap of 401.2M. Regarding current trading prices, SNOA is priced at $3.71, while AQST trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas AQST's P/E ratio is -6.96. In terms of profitability, SNOA's ROE is -0.71%, compared to AQST's ROE of +1.07%. Regarding short-term risk, SNOA is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs EBS Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, EBS has a market cap of 397.3M. Regarding current trading prices, SNOA is priced at $3.71, while EBS trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas EBS's P/E ratio is -2.84. In terms of profitability, SNOA's ROE is -0.71%, compared to EBS's ROE of -0.27%. Regarding short-term risk, SNOA is more volatile compared to EBS. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs SNDL Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, SNDL has a market cap of 364.1M. Regarding current trading prices, SNOA is priced at $3.71, while SNDL trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas SNDL's P/E ratio is -4.72. In terms of profitability, SNOA's ROE is -0.71%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, SNOA is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs LFCR Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, LFCR has a market cap of 325.3M. Regarding current trading prices, SNOA is priced at $3.71, while LFCR trades at $8.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas LFCR's P/E ratio is -5.98. In terms of profitability, SNOA's ROE is -0.71%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, SNOA is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ZYBT Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ZYBT has a market cap of 317M. Regarding current trading prices, SNOA is priced at $3.71, while ZYBT trades at $5.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ZYBT's P/E ratio is 111.50. In terms of profitability, SNOA's ROE is -0.71%, compared to ZYBT's ROE of +0.11%. Regarding short-term risk, SNOA is more volatile compared to ZYBT. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ALIM Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, SNOA is priced at $3.71, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ALIM's P/E ratio is 5.28. In terms of profitability, SNOA's ROE is -0.71%, compared to ALIM's ROE of -0.32%. Regarding short-term risk, SNOA is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs TKNO Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, TKNO has a market cap of 277.9M. Regarding current trading prices, SNOA is priced at $3.71, while TKNO trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas TKNO's P/E ratio is -11.82. In terms of profitability, SNOA's ROE is -0.71%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, SNOA is more volatile compared to TKNO. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ACB Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ACB has a market cap of 264.1M. Regarding current trading prices, SNOA is priced at $3.71, while ACB trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ACB's P/E ratio is 21.34. In terms of profitability, SNOA's ROE is -0.71%, compared to ACB's ROE of +0.00%. Regarding short-term risk, SNOA is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs LNDC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, SNOA is priced at $3.71, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas LNDC's P/E ratio is -4.04. In terms of profitability, SNOA's ROE is -0.71%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, SNOA is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs CGC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, CGC has a market cap of 246.1M. Regarding current trading prices, SNOA is priced at $3.71, while CGC trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas CGC's P/E ratio is -0.29. In terms of profitability, SNOA's ROE is -0.71%, compared to CGC's ROE of -1.13%. Regarding short-term risk, SNOA is more volatile compared to CGC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ESPR Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ESPR has a market cap of 245.8M. Regarding current trading prices, SNOA is priced at $3.71, while ESPR trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ESPR's P/E ratio is -1.46. In terms of profitability, SNOA's ROE is -0.71%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, SNOA is more volatile compared to ESPR. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs TYHT Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, SNOA is priced at $3.71, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas TYHT's P/E ratio is -1.61. In terms of profitability, SNOA's ROE is -0.71%, compared to TYHT's ROE of -1.41%. Regarding short-term risk, SNOA is more volatile compared to TYHT. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs OGI Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, OGI has a market cap of 196.1M. Regarding current trading prices, SNOA is priced at $3.71, while OGI trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas OGI's P/E ratio is 11.27. In terms of profitability, SNOA's ROE is -0.71%, compared to OGI's ROE of +0.05%. Regarding short-term risk, SNOA is more volatile compared to OGI. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs SXTC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, SXTC has a market cap of 193.8M. Regarding current trading prices, SNOA is priced at $3.71, while SXTC trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas SXTC's P/E ratio is 0.01. In terms of profitability, SNOA's ROE is -0.71%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, SNOA is more volatile compared to SXTC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs REPH Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, SNOA is priced at $3.71, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas REPH's P/E ratio is -8.04. In terms of profitability, SNOA's ROE is -0.71%, compared to REPH's ROE of -0.22%. Regarding short-term risk, SNOA is more volatile compared to REPH. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs DERM Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, DERM has a market cap of 168.5M. Regarding current trading prices, SNOA is priced at $3.71, while DERM trades at $7.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas DERM's P/E ratio is -19.55. In terms of profitability, SNOA's ROE is -0.71%, compared to DERM's ROE of -0.52%. Regarding short-term risk, SNOA is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs BIOA Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, BIOA has a market cap of 168M. Regarding current trading prices, SNOA is priced at $3.71, while BIOA trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas BIOA's P/E ratio is -2.37. In terms of profitability, SNOA's ROE is -0.71%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, SNOA is more volatile compared to BIOA. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs THTX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, THTX has a market cap of 144.8M. Regarding current trading prices, SNOA is priced at $3.71, while THTX trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas THTX's P/E ratio is -16.58. In terms of profitability, SNOA's ROE is -0.71%, compared to THTX's ROE of +0.16%. Regarding short-term risk, SNOA is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs IRWD Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, IRWD has a market cap of 126.4M. Regarding current trading prices, SNOA is priced at $3.71, while IRWD trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas IRWD's P/E ratio is -4.11. In terms of profitability, SNOA's ROE is -0.71%, compared to IRWD's ROE of +0.10%. Regarding short-term risk, SNOA is more volatile compared to IRWD. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs SCTL Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, SNOA is priced at $3.71, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas SCTL's P/E ratio is -7.86. In terms of profitability, SNOA's ROE is -0.71%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, SNOA is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs PROC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, PROC has a market cap of 114M. Regarding current trading prices, SNOA is priced at $3.71, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas PROC's P/E ratio is 1.53. In terms of profitability, SNOA's ROE is -0.71%, compared to PROC's ROE of -2.22%. Regarding short-term risk, SNOA is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs CRDL Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, CRDL has a market cap of 112.4M. Regarding current trading prices, SNOA is priced at $3.71, while CRDL trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas CRDL's P/E ratio is -4.00. In terms of profitability, SNOA's ROE is -0.71%, compared to CRDL's ROE of -2.10%. Regarding short-term risk, SNOA is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs OPTN Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, SNOA is priced at $3.71, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas OPTN's P/E ratio is -4.42. In terms of profitability, SNOA's ROE is -0.71%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, SNOA is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ZOM Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, SNOA is priced at $3.71, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ZOM's P/E ratio is -1.62. In terms of profitability, SNOA's ROE is -0.71%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, SNOA is more volatile compared to ZOM. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs GRVI Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, SNOA is priced at $3.71, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas GRVI's P/E ratio is 26.05. In terms of profitability, SNOA's ROE is -0.71%, compared to GRVI's ROE of +0.28%. Regarding short-term risk, SNOA is more volatile compared to GRVI. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs INCR Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, INCR has a market cap of 76.9M. Regarding current trading prices, SNOA is priced at $3.71, while INCR trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas INCR's P/E ratio is -3.79. In terms of profitability, SNOA's ROE is -0.71%, compared to INCR's ROE of -0.07%. Regarding short-term risk, SNOA is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ZYNE Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, SNOA is priced at $3.71, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, SNOA's ROE is -0.71%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, SNOA is more volatile compared to ZYNE. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ASRT Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ASRT has a market cap of 68M. Regarding current trading prices, SNOA is priced at $3.71, while ASRT trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ASRT's P/E ratio is -2.22. In terms of profitability, SNOA's ROE is -0.71%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, SNOA is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs SSIC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, SNOA is priced at $3.71, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas SSIC's P/E ratio is 11.93. In terms of profitability, SNOA's ROE is -0.71%, compared to SSIC's ROE of +0.09%. Regarding short-term risk, SNOA is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs VLNS Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, SNOA is priced at $3.71, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas VLNS's P/E ratio is -1.03. In terms of profitability, SNOA's ROE is -0.71%, compared to VLNS's ROE of N/A. Regarding short-term risk, SNOA is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs QNTM Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, QNTM has a market cap of 55.3M. Regarding current trading prices, SNOA is priced at $3.71, while QNTM trades at $18.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas QNTM's P/E ratio is -1.44. In terms of profitability, SNOA's ROE is -0.71%, compared to QNTM's ROE of -1.88%. Regarding short-term risk, SNOA is more volatile compared to QNTM. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs JUPW Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, SNOA is priced at $3.71, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas JUPW's P/E ratio is -2.41. In terms of profitability, SNOA's ROE is -0.71%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, SNOA is more volatile compared to JUPW. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs CPIX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, CPIX has a market cap of 48.9M. Regarding current trading prices, SNOA is priced at $3.71, while CPIX trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas CPIX's P/E ratio is -13.62. In terms of profitability, SNOA's ROE is -0.71%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, SNOA is more volatile compared to CPIX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs EGRX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, EGRX has a market cap of 46M. Regarding current trading prices, SNOA is priced at $3.71, while EGRX trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas EGRX's P/E ratio is 4.18. In terms of profitability, SNOA's ROE is -0.71%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, SNOA is more volatile compared to EGRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs KALA Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, KALA has a market cap of 44.5M. Regarding current trading prices, SNOA is priced at $3.71, while KALA trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas KALA's P/E ratio is -0.94. In terms of profitability, SNOA's ROE is -0.71%, compared to KALA's ROE of -3.69%. Regarding short-term risk, SNOA is less volatile compared to KALA. This indicates potentially lower risk in terms of short-term price fluctuations for SNOA.
SNOA vs RMTI Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, RMTI has a market cap of 44.3M. Regarding current trading prices, SNOA is priced at $3.71, while RMTI trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas RMTI's P/E ratio is -129.50. In terms of profitability, SNOA's ROE is -0.71%, compared to RMTI's ROE of -0.01%. Regarding short-term risk, SNOA is more volatile compared to RMTI. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs QLI Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, SNOA is priced at $3.71, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas QLI's P/E ratio is -4.92. In terms of profitability, SNOA's ROE is -0.71%, compared to QLI's ROE of -0.16%. Regarding short-term risk, SNOA is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs HEXO Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, SNOA is priced at $3.71, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas HEXO's P/E ratio is -0.26. In terms of profitability, SNOA's ROE is -0.71%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, SNOA is more volatile compared to HEXO. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs SCYX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, SCYX has a market cap of 27.3M. Regarding current trading prices, SNOA is priced at $3.71, while SCYX trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas SCYX's P/E ratio is -1.25. In terms of profitability, SNOA's ROE is -0.71%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, SNOA is more volatile compared to SCYX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs CYTH Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, SNOA is priced at $3.71, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas CYTH's P/E ratio is -0.80. In terms of profitability, SNOA's ROE is -0.71%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, SNOA is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs IXHL Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, IXHL has a market cap of 20.8M. Regarding current trading prices, SNOA is priced at $3.71, while IXHL trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas IXHL's P/E ratio is -0.18. In terms of profitability, SNOA's ROE is -0.71%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, SNOA is more volatile compared to IXHL. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs DRRX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, DRRX has a market cap of 19.1M. Regarding current trading prices, SNOA is priced at $3.71, while DRRX trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas DRRX's P/E ratio is -1.28. In terms of profitability, SNOA's ROE is -0.71%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, SNOA is less volatile compared to DRRX. This indicates potentially lower risk in terms of short-term price fluctuations for SNOA.
SNOA vs GELS Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, GELS has a market cap of 17.8M. Regarding current trading prices, SNOA is priced at $3.71, while GELS trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas GELS's P/E ratio is -7.87. In terms of profitability, SNOA's ROE is -0.71%, compared to GELS's ROE of -0.07%. Regarding short-term risk, SNOA is more volatile compared to GELS. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs PRPH Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, PRPH has a market cap of 17.8M. Regarding current trading prices, SNOA is priced at $3.71, while PRPH trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas PRPH's P/E ratio is -0.19. In terms of profitability, SNOA's ROE is -0.71%, compared to PRPH's ROE of -1.65%. Regarding short-term risk, SNOA is more volatile compared to PRPH. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs FLGC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, FLGC has a market cap of 16M. Regarding current trading prices, SNOA is priced at $3.71, while FLGC trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas FLGC's P/E ratio is -0.74. In terms of profitability, SNOA's ROE is -0.71%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, SNOA is more volatile compared to FLGC. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs ACRX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, SNOA is priced at $3.71, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas ACRX's P/E ratio is -0.31. In terms of profitability, SNOA's ROE is -0.71%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, SNOA is more volatile compared to ACRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs AYTU Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, AYTU has a market cap of 14.1M. Regarding current trading prices, SNOA is priced at $3.71, while AYTU trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas AYTU's P/E ratio is -1.54. In terms of profitability, SNOA's ROE is -0.71%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, SNOA is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs TXMD Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, TXMD has a market cap of 13.7M. Regarding current trading prices, SNOA is priced at $3.71, while TXMD trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas TXMD's P/E ratio is -6.24. In terms of profitability, SNOA's ROE is -0.71%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, SNOA is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs COSM Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, COSM has a market cap of 13.7M. Regarding current trading prices, SNOA is priced at $3.71, while COSM trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas COSM's P/E ratio is -0.43. In terms of profitability, SNOA's ROE is -0.71%, compared to COSM's ROE of -0.51%. Regarding short-term risk, SNOA is more volatile compared to COSM. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs TLPH Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, TLPH has a market cap of 10.5M. Regarding current trading prices, SNOA is priced at $3.71, while TLPH trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas TLPH's P/E ratio is -1.16. In terms of profitability, SNOA's ROE is -0.71%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, SNOA is more volatile compared to TLPH. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs AGRX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, SNOA is priced at $3.71, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas AGRX's P/E ratio is -0.89. In terms of profitability, SNOA's ROE is -0.71%, compared to AGRX's ROE of +0.93%. Regarding short-term risk, SNOA is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs IMCC Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, IMCC has a market cap of 10.4M. Regarding current trading prices, SNOA is priced at $3.71, while IMCC trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas IMCC's P/E ratio is -2.43. In terms of profitability, SNOA's ROE is -0.71%, compared to IMCC's ROE of -0.79%. Regarding short-term risk, SNOA is less volatile compared to IMCC. This indicates potentially lower risk in terms of short-term price fluctuations for SNOA.
SNOA vs SBFMW Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, SBFMW has a market cap of 9.1M. Regarding current trading prices, SNOA is priced at $3.71, while SBFMW trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas SBFMW's P/E ratio is -0.13. In terms of profitability, SNOA's ROE is -0.71%, compared to SBFMW's ROE of -0.21%. Regarding short-term risk, SNOA is less volatile compared to SBFMW. This indicates potentially lower risk in terms of short-term price fluctuations for SNOA.
SNOA vs EVOK Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, EVOK has a market cap of 9.1M. Regarding current trading prices, SNOA is priced at $3.71, while EVOK trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas EVOK's P/E ratio is -4.95. In terms of profitability, SNOA's ROE is -0.71%, compared to EVOK's ROE of -1.02%. Regarding short-term risk, SNOA is more volatile compared to EVOK. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs YCBD Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, YCBD has a market cap of 8.3M. Regarding current trading prices, SNOA is priced at $3.71, while YCBD trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas YCBD's P/E ratio is 0.01. In terms of profitability, SNOA's ROE is -0.71%, compared to YCBD's ROE of -0.01%. Regarding short-term risk, SNOA is more volatile compared to YCBD. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.
SNOA vs NLTX Comparison
SNOA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNOA stands at 6.4M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, SNOA is priced at $3.71, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNOA currently has a P/E ratio of -1.41, whereas NLTX's P/E ratio is -0.28. In terms of profitability, SNOA's ROE is -0.71%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, SNOA is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNOA.